<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To search for determinants of <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: We performed a comprehensive analysis of cardiovascular risk markers and measured blood flow responses to endothelium-dependent (<z:chebi fb="9" ids="15355">acetylcholine</z:chebi> [<z:chebi fb="0" ids="15355">ACh</z:chebi>] and <z:chebi fb="0" ids="28229">NG-monomethyl-L-arginine</z:chebi>) and -independent (<z:chebi fb="0" ids="29321">sodium nitroprusside</z:chebi> [SNP]) vasoactive agents in 30 nonsmoking men with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (age 51 +/- 1 years, BMI 27.8 +/- 0.4 kg/m2, HbA1c 7.4 +/- 0.3%) and 12 matched <z:mpath ids='MPATH_458'>normal</z:mpath> control men </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: <z:chebi fb="0" ids="15355">ACh</z:chebi>-induced vasodilation was 37% lower in type 2 diabetic (6.1 +/- 0.5) than in <z:mpath ids='MPATH_458'>normal</z:mpath> subjects (9.7 +/- 1.5 ml.dl-1.min-1, P &lt; 0.01), while flows during SNP were similar (9.1 +/- 0.6 vs. 9.9 +/- 1.3 ml.dl-1.min-1, NS) </plain></SENT>
<SENT sid="3" pm="."><plain>The ratio of endothelium-dependent vs. -independent flow (<z:chebi fb="0" ids="15355">ACh</z:chebi>:SNP ratio) was 31% lower in type 2 diabetic (0.70 +/- 0.05) than in <z:mpath ids='MPATH_458'>normal</z:mpath> subjects (1.10 +/- 0.18, P &lt; 0.01) </plain></SENT>
<SENT sid="4" pm="."><plain>Total (2.2 +/- 0.4 vs. 1.3 +/- 0.2 mmol/l, P &lt; 0.05), <z:chebi fb="1" ids="39027">VLDL</z:chebi>, and intermediate-density <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> <z:chebi fb="4" ids="17855">triglycerides</z:chebi> were significantly higher, and the mean <z:chebi fb="15" ids="39026">LDL</z:chebi> particle diameter was significantly smaller in type 2 diabetic than in <z:mpath ids='MPATH_458'>normal</z:mpath> subjects </plain></SENT>
<SENT sid="5" pm="."><plain>The lag times for <z:chebi fb="15" ids="39026">LDL</z:chebi> oxidation by Cu2+ in vitro were similar in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (183 +/- 7) and in <z:mpath ids='MPATH_458'>normal</z:mpath> subjects (183 +/- 9 min, NS) </plain></SENT>
<SENT sid="6" pm="."><plain>Measured and calculated (sum of concentration of individual <z:chebi fb="11" ids="22586">antioxidants</z:chebi> in serum) total <z:chebi fb="0" ids="25935">peroxyl radical</z:chebi>-trapping capacities (TRAPs) were comparable between the groups </plain></SENT>
<SENT sid="7" pm="."><plain>In the patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:chebi fb="15" ids="39026">LDL</z:chebi> size was significantly correlated with endothelium-dependent vasodilation (r = 0.43, P &lt; 0.05), serum <z:chebi fb="4" ids="17855">triglycerides</z:chebi> (r = -0.75, P &lt; 0.001), and the lag time for <z:chebi fb="15" ids="39026">LDL</z:chebi> oxidation in vitro (r = 0.38, P &lt; 0.05) </plain></SENT>
<SENT sid="8" pm="."><plain>HbA1c was inversely correlated with the lag time for <z:chebi fb="15" ids="39026">LDL</z:chebi> oxidation in vitro (r = -0.41, P &lt; 0.05) and TRAP </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: In summary, patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> exhibited impaired endothelium-dependent vasodilation in vivo, elevated serum <z:chebi fb="4" ids="17855">triglycerides</z:chebi>, decreased <z:chebi fb="15" ids="39026">LDL</z:chebi> size, and <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="11" ids="22586">antioxidant</z:chebi> capacity </plain></SENT>
<SENT sid="10" pm="."><plain>Of these parameters, <z:chebi fb="15" ids="39026">LDL</z:chebi> size was significantly correlated with endothelial function </plain></SENT>
</text></document>